• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 15, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Breast cancer disparity equally impacted by social determinants of health, tumor biology

Bioengineer by Bioengineer
February 16, 2023
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at the University of Illinois Chicago examined national data about women with early-stage, estrogen receptor-positive breast cancer and found that social determinants of health and tumor biology contributed equally to higher rates of death among Black women.

Kent Hoskins_V

Credit: University of Illinois Chicago/Jenny Fontaine

Researchers at the University of Illinois Chicago examined national data about women with early-stage, estrogen receptor-positive breast cancer and found that social determinants of health and tumor biology contributed equally to higher rates of death among Black women.

The study, published in JAMA Oncology, is the first study of breast cancer disparities to include a genomic biomarker of tumor aggression in the analysis of the proportion of the disparity mediated by tumor biology.

The researchers say that their findings validate the role of social determinants of health as a root cause of racial disparities in breast cancer outcomes and also suggest that to eliminate the survival gap, which was first documented more than four decades ago, we need “a clearer picture of the biological mechanisms underlying the aggressive tumor phenotype that is more prevalent in Black women, and insight into the complex relationship between adverse social conditions, ancestry-related genetic variants and tumor biology.”

“Adverse social determinants of health are well-known root causes of the racial disparity in breast cancer survival. This study added to our understanding of this public health problem by demonstrating conclusively that disproportionately aggressive tumor biology in Black women not only contributes to disparate outcomes but appears to be as important as social disadvantage,” said lead author Dr. Kent Hoskins, the Eileen Lindsay Heidrick Professor of Oncology in the College of Medicine and associate director of translational research in the University of Illinois Cancer Center at UIC. “The study also suggested that social factors may actually be driving some of the racial difference in tumor biology.”

For their analysis, the researchers reviewed data available through the National Cancer Institute’s Surveillance, Epidemiology and End Results Program. They looked at stage 1 and stage 2 estrogen receptor-positive breast cancers, the most common type of breast cancer that generally has the most favorable prognosis, with cases that were diagnosed between 2004-2015.

Data from 60,137 Black and non-Hispanic white women were included in the study.

The researchers calculated the effect of social determinants of health — specifically neighborhood disadvantage and insurance status — on mortality and found they accounted for 19% of the disparity. They also calculated the effect of biological characteristics of the tumors by looking at data from genomic laboratory test results, which were used to anticipate tumor response to chemotherapy and likelihood of recurrence. They found tumor biology accounted for 20% of the disparity.

They also found, similar to many other studies, that white women were more likely than Black women to be in the highest income and education groups and in the lowest poverty group, and to have health insurance. Black women were more likely to have aggressive tumors with a high risk of recurrence, to be diagnosed at stage 2 and to receive chemotherapy.

“By focusing our analysis on women with ER-positive tumors and by including tumor genomics as a mediating variable, we were able to more precisely quantify the relative excess of breast cancer death mediated by aggressive tumor biology in Black women with the most common breast cancer subtype,” the authors wrote.

Hoskins said this adds to evidence that the UIC team generated over the past few years indicating that the tools used to determine the best treatments for patients, like the genomic oncotype tests used for patients in the study, may not be serving Black women as well as white women.

“The tools we have to aid in decision-making regarding treatments do not take into account potential differences in tumor biology across race and ethnicity, and even worse could be providing misleading information or a false sense of security with treatment decisions for Black women,” Hoskins said.

Co-authors of the study “Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer” are Gregory S. Calip, Hsiao-Ching Huang, Dr. Abiola Ibraheem, Dr. Oana C. Danciu and Dr. Garth H. Rauscher.



Journal

JAMA Oncology

DOI

10.1001/jamaoncol.2022.7705

Method of Research

Data/statistical analysis

Subject of Research

People

Article Title

Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer

Article Publication Date

16-Feb-2023

Share12Tweet8Share2ShareShareShare2

Related Posts

Acidulant and VERDAD N6 Enhance Tteokbokki Quality

Acidulant and VERDAD N6 Enhance Tteokbokki Quality

August 15, 2025
blank

Sparring Saigas Triumph at the 2025 BMC Journals Image Competition

August 15, 2025

“‘Use It or Lose It’: The Island That Transformed a Bird Species”

August 15, 2025

Breast Milk Antibodies Shape Early Immune Development in Mouse Intestine

August 15, 2025

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    140 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    79 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    58 shares
    Share 23 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Acidulant and VERDAD N6 Enhance Tteokbokki Quality

Sustainable Innovation: Advancing High-Yield, Eco-Friendly Technologies

Innovative Network Offers Promising Advances in Predicting Health Issues in Dogs

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.